- Home
- CBRL vs RCUS Comparison
CBRL vs RCUS Comparison
Compare CBRL & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRL
- RCUS
- Stock Information
- Founded
- CBRL 1969
- RCUS 2015
- Country
- CBRL United States
- RCUS United States
- Employees
- CBRL N/A
- RCUS N/A
- Industry
- CBRL Restaurants
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- CBRL Consumer Discretionary
- RCUS Health Care
- Exchange
- CBRL Nasdaq
- RCUS Nasdaq
- Market Cap
- CBRL 986.7M
- RCUS 1.2B
- IPO Year
- CBRL N/A
- RCUS 2018
- Fundamental
- Price
- CBRL $36.74
- RCUS $7.05
- Analyst Decision
- CBRL Hold
- RCUS Strong Buy
- Analyst Count
- CBRL 9
- RCUS 10
- Target Price
- CBRL $52.43
- RCUS $29.50
- AVG Volume (30 Days)
- CBRL 1.2M
- RCUS 939.9K
- Earning Date
- CBRL 03-06-2025
- RCUS 05-07-2025
- Dividend Yield
- CBRL 2.77%
- RCUS N/A
- EPS Growth
- CBRL N/A
- RCUS N/A
- EPS
- CBRL 1.60
- RCUS N/A
- Revenue
- CBRL $3,506,050,000.00
- RCUS $258,000,000.00
- Revenue This Year
- CBRL $1.88
- RCUS N/A
- Revenue Next Year
- CBRL $1.87
- RCUS $25.77
- P/E Ratio
- CBRL $22.51
- RCUS N/A
- Revenue Growth
- CBRL 2.26
- RCUS 120.51
- 52 Week Low
- CBRL $34.88
- RCUS $7.14
- 52 Week High
- CBRL $71.13
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- CBRL 31.97
- RCUS 23.93
- Support Level
- CBRL $38.79
- RCUS $7.51
- Resistance Level
- CBRL $41.63
- RCUS $7.93
- Average True Range (ATR)
- CBRL 1.83
- RCUS 0.42
- MACD
- CBRL -0.03
- RCUS -0.07
- Stochastic Oscillator
- CBRL 14.65
- RCUS 3.65
About CBRL Cracker Barrel Old Country Store Inc
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. Its restaurants are open for breakfast, lunch, and dinner, with menus that offer home-style country food. Cracker Barrel's biggest input costs are beef, dairy, fruits and vegetables, pork, and poultry. The company purchases its food products from a few different vendors on a cost-plus basis. All restaurants are located in freestanding buildings and include gift shops, which contribute roughly one fourth of total company revenue. Apparel and accessories are the company's biggest revenue generators in the retail segment of the business.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.